BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30702142)

  • 1. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
    Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Masch R; Cremer M; Kim JJ
    Int J Gynaecol Obstet; 2019 Apr; 145(1):40-46. PubMed ID: 30702142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
    Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Cremer ML; Kim JJ
    Int J Cancer; 2015 Aug; 137(4):893-902. PubMed ID: 25639903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador.
    Campos NG; Alfaro K; Maza M; Sy S; Melendez M; Masch R; Soler M; Conzuelo-Rodriguez G; Gage JC; Alonzo TA; Castle PE; Felix JC; Cremer M; Kim JJ
    Prev Med; 2020 Feb; 131():105931. PubMed ID: 31765712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.
    Campos NG; Mvundura M; Jeronimo J; Holme F; Vodicka E; Kim JJ
    BMJ Open; 2017 Jun; 7(6):e015048. PubMed ID: 28619772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador.
    Cremer M; Maza M; Alfaro K; Morales Velado M; Felix J; Castle PE; Kim J; Gage JC
    J Low Genit Tract Dis; 2017 Jan; 21(1):26-32. PubMed ID: 27922905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
    Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
    BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador.
    Cremer ML; Maza M; Alfaro KM; Kim JJ; Ditzian LR; Villalta S; Alonzo TA; Felix JC; Castle PE; Gage JC
    J Low Genit Tract Dis; 2016 Apr; 20(2):145-50. PubMed ID: 26890683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.
    Campos NG; Tsu V; Jeronimo J; Njama-Meya D; Mvundura M; Kim JJ
    Health Policy Plan; 2017 Sep; 32(7):956-968. PubMed ID: 28369405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
    Kim JJ; Burger EA; Sy S; Campos NG
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
    Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
    Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country.
    Vanni T; Luz PM; Grinsztejn B; Veloso VG; Foss A; Mesa-Frias M; Legood R
    Int J Cancer; 2012 Jul; 131(2):E96-104. PubMed ID: 21964797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El Salvador.
    Alfaro K; Maza M; Felix JC; Gage JC; Castle PE; Alonzo TA; Chacón A; González E; Soler M; Conzuelo-Rodriguez G; Masch R; Cremer M
    JCO Glob Oncol; 2020 Oct; 6():1519-1530. PubMed ID: 33064628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study.
    Campos NG; Lince-Deroche N; Chibwesha CJ; Firnhaber C; Smith JS; Michelow P; Meyer-Rath G; Jamieson L; Jordaan S; Sharma M; Regan C; Sy S; Liu G; Tsu V; Jeronimo J; Kim JJ
    J Acquir Immune Defic Syndr; 2018 Oct; 79(2):195-205. PubMed ID: 29916959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical Cancer Screening with Human Papillomavirus Self-Sampling Among Transgender Men in El Salvador.
    Maza M; Meléndez M; Herrera A; Hernández X; Rodríguez B; Soler M; Alfaro K; Masch R; Conzuelo-Rodríguez G; Obedin-Maliver J; Cremer M
    LGBT Health; 2020; 7(4):174-181. PubMed ID: 32407149
    [No Abstract]   [Full Text] [Related]  

  • 16. The budget impact of cervical cancer screening using HPV primary screening.
    Wright T; Huang J; Baker E; Garfield S; Hertz D; Cox JT
    Am J Manag Care; 2016 Mar; 22(3):e95-105. PubMed ID: 26978241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador.
    Maza M; Melendez M; Masch R; Alfaro K; Chacon A; Gonzalez E; Soler M; Conzuelo-Rodriguez G; Gage JC; Alonzo TA; Castle PE; Felix JC; Cremer M
    Prev Med; 2018 Sep; 114():149-155. PubMed ID: 29958860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model to evaluate the costs and clinical effectiveness of human papilloma virus screening compared with annual papanicolaou cytology in Germany.
    Petry KU; Barth C; Wasem J; Neumann A
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():132-139. PubMed ID: 28363186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway.
    Burger EA; Ortendahl JD; Sy S; Kristiansen IS; Kim JJ
    Br J Cancer; 2012 Apr; 106(9):1571-8. PubMed ID: 22441643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.
    Laskow B; Figueroa R; Alfaro KM; Scarinci IC; Conlisk E; Maza M; Chang JC; Cremer M
    Int J Gynaecol Obstet; 2017 Aug; 138(2):194-200. PubMed ID: 28589548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.